Trials / Terminated
TerminatedNCT04745806
Post Marketing Trial for Evaluating the Effectiveness of ActiGraft in Treating Lower Extremity Hard To Heal Wounds
A Prospective, Single Arm, Post Marketing Study for Evaluating the Effectiveness of ActiGraft in Treating Lower Extremity Hard to Heal Wounds
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- RedDress Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is a prospective, single arm, post- marketing study. The subjects enrolled to the study will receive weekly applications of ActiGraft until complete healing or until investigator's decision that patient can no longer benefit from the study treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ActiGraft | Whole blood clot (WBC) gel |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2023-01-01
- Completion
- 2023-01-01
- First posted
- 2021-02-09
- Last updated
- 2024-11-15
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT04745806. Inclusion in this directory is not an endorsement.